Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Rechkoblit

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|June 14, 2002
trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerasesOlga Rechkoblit, Yanbin Zhang, Dongyu Guo, et al.
Science Advances|November 8, 2016
Structure and mechanism of human PrimPol, a DNA polymerase with primase activityOlga Rechkoblit, Yogesh K Gupta, Radhika Malik, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
<i>Burkholderia cenocepacia</i> epigenetic regulator M.BceJIV simultaneously engages two DNA recognition sequences for methylationRichard Quintana-Feliciano, Jithesh Kottur, Mi Ni, et al.
Plos Pathogens|July 31, 2023
Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antiviralsJithesh Kottur, Kris M White, M Luis Rodriguez, et al.
Nature Communications|September 7, 2024
Burkholderia cenocepacia epigenetic regulator M.BceJIV simultaneously engages two DNA recognition sequences for methylationRichard Quintana-Feliciano, Jithesh Kottur, Mi Ni, et al.
Nature Structural & Molecular Biology|May 8, 2012
Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyAjay Ummat, Olga Rechkoblit, Rinku Jain, et al.
Oncotarget|February 1, 2019
Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemiaAmol Padgaonkar, Olga Rechkoblit, Rodgrigo Vasquez-Del Carpio, et al.
Nature Communications|August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant diseaseKatsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Biological Chemistry|June 14, 2002
trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerasesOlga Rechkoblit, Yanbin Zhang, Dongyu Guo, et al.
Science Advances|November 8, 2016
Structure and mechanism of human PrimPol, a DNA polymerase with primase activityOlga Rechkoblit, Yogesh K Gupta, Radhika Malik, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
<i>Burkholderia cenocepacia</i> epigenetic regulator M.BceJIV simultaneously engages two DNA recognition sequences for methylationRichard Quintana-Feliciano, Jithesh Kottur, Mi Ni, et al.
Plos Pathogens|July 31, 2023
Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antiviralsJithesh Kottur, Kris M White, M Luis Rodriguez, et al.
Nature Communications|September 7, 2024
Burkholderia cenocepacia epigenetic regulator M.BceJIV simultaneously engages two DNA recognition sequences for methylationRichard Quintana-Feliciano, Jithesh Kottur, Mi Ni, et al.
Nature Structural & Molecular Biology|May 8, 2012
Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyAjay Ummat, Olga Rechkoblit, Rinku Jain, et al.
Oncotarget|February 1, 2019
Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemiaAmol Padgaonkar, Olga Rechkoblit, Rodgrigo Vasquez-Del Carpio, et al.
Nature Communications|August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant diseaseKatsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.
Pageof 3